Affymetrix Rolls Out OncoScan Service for Profiling FFPE Cancer Samples | GenomeWeb

By Justin Petrone

Affymetrix last week introduced a new service that will allow its customers to profile formalin-fixed, paraffin-embedded samples on its GeneChip microarray platform.

CEO Kevin King said that the new service, called OncoScan FFPE Express, is "being used by many cancer centers around the world in population studies for the most challenging samples." King spoke to investors about OncoScan FFPE at the UBS Global Life Sciences Conference last week in New York.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Through a transcriptome study, researchers home in on the activity of inflammation-linked genes in chronically lonely people.

Determining who is and is not an author and where a researcher should fall on a list of authors can be a tricky task, Nature News writes.

In PNAS this week: variant protective against Alzheimer's disease, effect of whole-genome duplication on methylation in rice, and more.

Genome editing is also bringing up questions when applied to farm animals, the New York Times reports.

Sponsored by
Agilent Technologies

This online seminar will discuss a metagenomic assay to identify viruses and other pathogenic microorganisms in human tumor samples, with the aim of gaining a more comprehensive understanding of the role of the microbiome in cancer development and treatment.